Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Quaranta

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical and Translational Science|February 15, 2020
A Simple and Rapid UPLC-UV Method for Detecting DPD Deficiency in Patients With CancerClémence Marin, Anis Krache, Chloé Palmaro, et al.
Pharmacogenomics|September 6, 2019
Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiencyCrescent C Gbeto, Sylvie Quaranta, Roxane Mari, et al.
L'Encephale|November 15, 2024
CYP2D6 and CYP2C19 ultrarapid metabolisms are associated with suicide attempts in schizophreniaThéo Korchia, Melanie Faugere, Maud Tastevin, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Toxicology Letters|January 31, 2006
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French populationSylvie Quaranta, Dany Chevalier, Véronique Bourgarel-Rey, et al.
Biochemical and Biophysical Research Communications|April 6, 2004
Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibilityChristelle Cauffiez, Jean-Marc Lo-Guidice, Sylvie Quaranta, et al.
Antiviral Therapy|September 2, 2016
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, et al.
Bulletin Du Cancer|July 1, 2014
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan]Jean-Christophe Boyer, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, et al.
Fundamental & Clinical Pharmacology|March 31, 2015
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practiceMarie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical and Translational Science|February 15, 2020
A Simple and Rapid UPLC-UV Method for Detecting DPD Deficiency in Patients With CancerClémence Marin, Anis Krache, Chloé Palmaro, et al.
Pharmacogenomics|September 6, 2019
Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiencyCrescent C Gbeto, Sylvie Quaranta, Roxane Mari, et al.
L'Encephale|November 15, 2024
CYP2D6 and CYP2C19 ultrarapid metabolisms are associated with suicide attempts in schizophreniaThéo Korchia, Melanie Faugere, Maud Tastevin, et al.
British Journal of Clinical Pharmacology|May 23, 2007
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCaroline Solas, Nicolas Simon, Marie-Pierre Drogoul, et al.
AIDS (London, England)|May 6, 2016
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapyFarid Kheloufi, Eric Bellissant, Laurent Cotte, et al.
Toxicology Letters|January 31, 2006
Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French populationSylvie Quaranta, Dany Chevalier, Véronique Bourgarel-Rey, et al.
Biochemical and Biophysical Research Communications|April 6, 2004
Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibilityChristelle Cauffiez, Jean-Marc Lo-Guidice, Sylvie Quaranta, et al.
Antiviral Therapy|September 2, 2016
ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, et al.
Bulletin Du Cancer|July 1, 2014
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan]Jean-Christophe Boyer, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, et al.
Fundamental & Clinical Pharmacology|March 31, 2015
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practiceMarie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, et al.
Pageof 4